MDXG · Mimedx Group Inc
United States · RS rating 66 · As of 2026-10-14
| Price | 4.70 USD |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 66 / 65 / 81 / 23 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 22 / 32 / 9 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | -9.1% |
| Sales growth Q/Q | +3.8% |
| Distance from 52-week high | +41.0% |
| Market cap (USD) | $497.7M |